Clinical Trial Update: A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study comparing enzalutamide capsule vs tablet for relative bioavailability after a single fasted dose in healthy male subjects; the trial has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Healthy Subjects, Castration Resistant Prostate Cancer (CRPC) | Phase 1 | Status: COMPLETED